Go back

$176m to support Moderna pandemic flu vaccine effort

Image: KitzD66, via Pixabay

US federal support aims to build on success of vaccine against Covid-19

The US federal government has awarded $176 million to the biotechnology company Moderna to support its efforts to develop a vaccine against pandemic influenza.

Announced on 2 July, the award from the Biomedical Advanced Research and Development Authority is for work using the mRNA technology Moderna used to develop one of the first vaccines against Covid-19.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.